title: Stable and unstable transgene integration sites in the human genome: extinction of the Green Fluorescent Protein transgene in K562 cells.
abstract: In gene transfer experiments including gene therapy studies, expression of the integrated transgenes in host cells often declines with time. The molecular basis of this phenomenon is not clearly understood. We have used the Green Fluorescent Protein (GFP) gene as both a selectable marker and a reporter to study long-term transgene integration and expression in K562 cells. Cells transfected with plasmids containing the GFP gene coupled to the HS2 or HS3 enhancer of the human beta-globin Locus Control Region (LCR) or the cytomegalovirus (CMV) enhancer were sorted by either fluorescence-activated-cell-sorting (FACS) alone or FACS combined with drug selection based on a co-integrated drug resistance gene. The two groups of selected cells were subsequently cultured for long periods up to 250 cell generations. Comparison of long-term GFP transgene integration and expression in these two groups of cells revealed that the K562 genome contains two types of transgene integration sites: i) abundant unstable sites that permit transcription but not long-term integration of the transgenes and thus eliminate the transgenes in 60-250 cell generations and ii) rare stable sites that permit both efficient transcription and long-term stable integration of the transgenes for at least 200 cell generations. Our results indicate that extinction of GFP expression with time is due at least in part to elimination of the gene from the host genome and not entirely to transcriptional silencing of the gene. However, long-term, stable expression of the transgene can be achieved in cells containing the transgene integrated into the rare, stable host sites.
authors.affiliation: Laboratorio di Biologia Cellulare, Instituto Superiore di Sanita, Rome, Italy.
authors.forename: A R
authors.initials: AR
authors.lastname: Migliaccio
authors.forename: C
authors.initials: C
authors.lastname: Bengra
authors.forename: J
authors.initials: J
authors.lastname: Ling
authors.forename: W
authors.initials: W
authors.lastname: Pi
authors.forename: C
authors.initials: C
authors.lastname: Li
authors.forename: S
authors.initials: S
authors.lastname: Zeng
authors.forename: M
authors.initials: M
authors.lastname: Keskintepe
authors.forename: B
authors.initials: B
authors.lastname: Whitney
authors.forename: M
authors.initials: M
authors.lastname: Sanchez
authors.forename: G
authors.initials: G
authors.lastname: Migliaccio
authors.forename: D
authors.initials: D
authors.lastname: Tuan
mesh_terms: D001665:Binding Sites; D002455:Cell Division; D002469:Cell Separation; D015500:Chloramphenicol O-Acetyltransferase / Q000235:genetics / Q000378:metabolism; D002999:Clone Cells; D005434:Flow Cytometry; D005453:Fluorescence; D005786:Gene Expression Regulation; D015894:Genome, Human; D049452:Green Fluorescent Proteins; D006801:Humans; D020014:K562 Cells; D008164:Luminescent Proteins / Q000235:genetics / Q000378:metabolism; D010957:Plasmids / Q000235:genetics; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000378:metabolism; D013997:Time Factors; D014158:Transcription, Genetic; D014162:Transfection; D019076:Transgenes / Q000235:genetics*
chemical_list: D008164:Luminescent Proteins; D011993:Recombinant Fusion Proteins; D049452:Green Fluorescent Proteins; D015500:Chloramphenicol O-Acetyltransferase